Capecitabine Norameda

Medicinal product

(Invented) name

Capecitabine Norameda

Active substance (s)

Kapecitabinas

Strength

150 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01BC06, Capecitabine

Marketing authorisation holder

UAB Norameda, Lietuva

Date of authorisation

2013-05-15

Date of renewal

2018-10-08

Documents

3296_1-2 Capecitabine Norameda_perr2018-10-08.docx

3296_01-02 Pakuotes lapelis_2018-10-08.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

LV/H/0179/001/

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Kapecitabinas	150 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
47376	61192	1061192	lizdinė plokštelė	N60		Receptinis	LT/1/13/3296/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-10-30	Išregistruotas
2018-10-08	Perregistruotas
2013-05-15	Registruotas